Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-046238
Filing Date
2024-11-12
Accepted
2024-11-12 17:24:04
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 ny20037443x1_s3.htm S-3 565712
2 EXHIBIT 1.2 ny20037443x1_ex1-2.htm EX-1.2 17030
3 EXHIBIT 4.3 ny20037443x1_ex4-3.htm EX-4.3 327285
4 EXHIBIT 4.5 ny20037443x1_ex4-5.htm EX-4.5 108475
5 EXHIBIT 4.6 ny20037443x1_ex4-6.htm EX-4.6 113346
6 EXHIBIT 4.7 ny20037443x1_ex4-7.htm EX-4.7 99423
7 EXHIBIT 5.1 ny20037443x1_ex5-1.htm EX-5.1 35671
8 EXHIBIT 23.1 ny20037443x1_ex23-1.htm EX-23.1 2653
9 EXHIBIT 107 ny20037443x1_ex107.htm EX-FILING FEES 29887
10 logo_sangamo.jpg GRAPHIC 74853
11 logo_sangamox1.jpg GRAPHIC 42770
12 ny20037443x1_ex5-1image01.jpg GRAPHIC 2981
  Complete submission text file 0001140361-24-046238.txt   1466504
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283179 | Film No.: 241450001
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)